Selected research
Industry Growth & Trends
Global Pemetrexed Diacid Industry Growth and Trends Forecast to 2032
Market perspective
The global Pemetrexed Diacid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pemetrexed Diacid include Qilu Pharma, Nanjing Pharmaceutical Factory Co., Ltd., Lianyungang Tengfa Bio-tech Co., Ltd., Eli Lilly and Company, United Biotech India Pvt.Ltd., Pemgem, Onkos, Natco Pharma Ltd and Emcure, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pemetrexed Diacid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pemetrexed Diacid market size, estimates, and forecasts are presented in terms of sales volume (doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pemetrexed Diacid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pemetrexed Diacid.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pemetrexed Diacid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pemetrexed Diacid Market by Company
Qilu Pharma
Nanjing Pharmaceutical Factory Co., Ltd.
Lianyungang Tengfa Bio-tech Co., Ltd.
Eli Lilly and Company
United Biotech India Pvt.Ltd.
Pemgem
Onkos
Natco Pharma Ltd
Emcure
Cytotoxic
ChemOthersapy
Beacon Pharma
Actiza Parma
Pemetrexed Diacid Segment by Type
500mg Injection
300mg Injection
200mg Injection
100mg Injection
Pemetrexed Diacid Segment by Application
Mesothelioma
Non-Small Cell Lung Cancer
Others
Pemetrexed Diacid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Diacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Diacid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Diacid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pemetrexed Diacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg Injection
- 300mg Injection
- 200mg Injection
- 100mg Injection
Applications
- Mesothelioma
- Non-Small Cell Lung Cancer
- Others
Companies covered
- Qilu Pharma
- Nanjing Pharmaceutical Factory Co., Ltd.
- Lianyungang Tengfa Bio-tech Co., Ltd.
- Eli Lilly and Company
- United Biotech India Pvt.Ltd.
- Pemgem
- Onkos
- Natco Pharma Ltd
- Emcure
- Cytotoxic
- ChemOthersapy
- Beacon Pharma
- Actiza Parma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pemetrexed Diacid Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pemetrexed Diacid Sales Estimates and Forecasts (2021-2032)
- 1.3 Pemetrexed Diacid Market by Type
- 1.3.1 500mg Injection
- 1.3.2 300mg Injection
- 1.3.3 200mg Injection
- 1.3.4 100mg Injection
- 1.4 Global Pemetrexed Diacid Market Size by Type
- 1.4.1 Global Pemetrexed Diacid Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pemetrexed Diacid Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pemetrexed Diacid Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pemetrexed Diacid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pemetrexed Diacid Industry Trends
- 2.2 Pemetrexed Diacid Industry Drivers
- 2.3 Pemetrexed Diacid Industry Opportunities and Challenges
- 2.4 Pemetrexed Diacid Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pemetrexed Diacid Revenue (2021-2026)
- 3.2 Global Top Players by Pemetrexed Diacid Sales (2021-2026)
- 3.3 Global Top Players by Pemetrexed Diacid Price (2021-2026)
- 3.4 Global Pemetrexed Diacid Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pemetrexed Diacid Major Company Production Sites & Headquarters
- 3.6 Global Pemetrexed Diacid Company, Product Type & Application
- 3.7 Global Pemetrexed Diacid Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pemetrexed Diacid Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pemetrexed Diacid Players Market Share by Revenue in 2025
- 3.8.3 2025 Pemetrexed Diacid Tier 1, Tier 2, and Tier 3
4 Pemetrexed Diacid Regional Status and Outlook
- 4.1 Global Pemetrexed Diacid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pemetrexed Diacid Historic Market Size by Region
- 4.2.1 Global Pemetrexed Diacid Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pemetrexed Diacid Sales in Value by Region (2021-2026)
- 4.2.3 Global Pemetrexed Diacid Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pemetrexed Diacid Forecasted Market Size by Region
- 4.3.1 Global Pemetrexed Diacid Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pemetrexed Diacid Sales in Value by Region (2027-2032)
- 4.3.3 Global Pemetrexed Diacid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pemetrexed Diacid by Application
- 5.1 Pemetrexed Diacid Market by Application
- 5.1.1 Mesothelioma
- 5.1.2 Non-Small Cell Lung Cancer
- 5.1.3 Others
- 5.2 Global Pemetrexed Diacid Market Size by Application
- 5.2.1 Global Pemetrexed Diacid Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pemetrexed Diacid Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pemetrexed Diacid Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pemetrexed Diacid Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Qilu Pharma
- 6.1.1 Qilu Pharma Company Information
- 6.1.2 Qilu Pharma Business Overview
- 6.1.3 Qilu Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
- 6.1.5 Qilu Pharma Recent Developments
- 6.2 Nanjing Pharmaceutical Factory Co., Ltd.
- 6.2.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
- 6.2.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
- 6.2.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
- 6.2.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
- 6.3 Lianyungang Tengfa Bio-tech Co., Ltd.
- 6.3.1 Lianyungang Tengfa Bio-tech Co., Ltd. Company Information
- 6.3.2 Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview
- 6.3.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
- 6.3.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments
- 6.4 Eli Lilly and Company
- 6.4.1 Eli Lilly and Company Company Information
- 6.4.2 Eli Lilly and Company Business Overview
- 6.4.3 Eli Lilly and Company Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
- 6.4.5 Eli Lilly and Company Recent Developments
- 6.5 United Biotech India Pvt.Ltd.
- 6.5.1 United Biotech India Pvt.Ltd. Company Information
- 6.5.2 United Biotech India Pvt.Ltd. Business Overview
- 6.5.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
- 6.5.5 United Biotech India Pvt.Ltd. Recent Developments
- 6.6 Pemgem
- 6.6.1 Pemgem Company Information
- 6.6.2 Pemgem Business Overview
- 6.6.3 Pemgem Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pemgem Pemetrexed Diacid Product Portfolio
- 6.6.5 Pemgem Recent Developments
- 6.7 Onkos
- 6.7.1 Onkos Company Information
- 6.7.2 Onkos Business Overview
- 6.7.3 Onkos Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Onkos Pemetrexed Diacid Product Portfolio
- 6.7.5 Onkos Recent Developments
- 6.8 Natco Pharma Ltd
- 6.8.1 Natco Pharma Ltd Company Information
- 6.8.2 Natco Pharma Ltd Business Overview
- 6.8.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
- 6.8.5 Natco Pharma Ltd Recent Developments
- 6.9 Emcure
- 6.9.1 Emcure Company Information
- 6.9.2 Emcure Business Overview
- 6.9.3 Emcure Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Emcure Pemetrexed Diacid Product Portfolio
- 6.9.5 Emcure Recent Developments
- 6.10 Cytotoxic
- 6.10.1 Cytotoxic Company Information
- 6.10.2 Cytotoxic Business Overview
- 6.10.3 Cytotoxic Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Cytotoxic Pemetrexed Diacid Product Portfolio
- 6.10.5 Cytotoxic Recent Developments
- 6.11 ChemOthersapy
- 6.11.1 ChemOthersapy Company Information
- 6.11.2 ChemOthersapy Business Overview
- 6.11.3 ChemOthersapy Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
- 6.11.5 ChemOthersapy Recent Developments
- 6.12 Beacon Pharma
- 6.12.1 Beacon Pharma Company Information
- 6.12.2 Beacon Pharma Business Overview
- 6.12.3 Beacon Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
- 6.12.5 Beacon Pharma Recent Developments
- 6.13 Actiza Parma
- 6.13.1 Actiza Parma Company Information
- 6.13.2 Actiza Parma Business Overview
- 6.13.3 Actiza Parma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Actiza Parma Pemetrexed Diacid Product Portfolio
- 6.13.5 Actiza Parma Recent Developments
7 North America by Country
- 7.1 North America Pemetrexed Diacid Sales by Country
- 7.1.1 North America Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pemetrexed Diacid Sales by Country (2021-2026)
- 7.1.3 North America Pemetrexed Diacid Sales Forecast by Country (2027-2032)
- 7.2 North America Pemetrexed Diacid Market Size by Country
- 7.2.1 North America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pemetrexed Diacid Market Size by Country (2021-2026)
- 7.2.3 North America Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pemetrexed Diacid Sales by Country
- 8.1.1 Europe Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pemetrexed Diacid Sales by Country (2021-2026)
- 8.1.3 Europe Pemetrexed Diacid Sales Forecast by Country (2027-2032)
- 8.2 Europe Pemetrexed Diacid Market Size by Country
- 8.2.1 Europe Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pemetrexed Diacid Market Size by Country (2021-2026)
- 8.2.3 Europe Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pemetrexed Diacid Sales by Country
- 9.1.1 Asia-Pacific Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pemetrexed Diacid Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pemetrexed Diacid Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pemetrexed Diacid Market Size by Country
- 9.2.1 Asia-Pacific Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pemetrexed Diacid Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pemetrexed Diacid Sales by Country
- 10.1.1 South America Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pemetrexed Diacid Sales by Country (2021-2026)
- 10.1.3 South America Pemetrexed Diacid Sales Forecast by Country (2027-2032)
- 10.2 South America Pemetrexed Diacid Market Size by Country
- 10.2.1 South America Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pemetrexed Diacid Market Size by Country (2021-2026)
- 10.2.3 South America Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pemetrexed Diacid Sales by Country
- 11.1.1 Middle East and Africa Pemetrexed Diacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pemetrexed Diacid Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pemetrexed Diacid Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pemetrexed Diacid Market Size by Country
- 11.2.1 Middle East and Africa Pemetrexed Diacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pemetrexed Diacid Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pemetrexed Diacid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pemetrexed Diacid Value Chain Analysis
- 12.1.1 Pemetrexed Diacid Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pemetrexed Diacid Production Mode & Process
- 12.2 Pemetrexed Diacid Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pemetrexed Diacid Distributors
- 12.2.3 Pemetrexed Diacid Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst